| ||
| Generic Taxotere Gets FDA Marketing Okay MedPage Today By Cole Petrochko, Staff Writer, MedPage Today WASHINGTON -- The FDA has approved marketing of generic docetaxel -- previously under patent and sold as Taxotere by sanofi-aventis. Generic drugmaker Hospira will distribute docetaxel in a single-vial ... See all stories on this topic » | ||
| CVMP Adopts Positive Opinion For Marketing Of Zuprevo Wall Street Journal LONDON (Dow Jones)--The Committee for Medicinal Products for Veterinary Use, or CVMP, said Friday it adopted positive opinion for an initial marketing authorization application for Zuprevo from Intervet International BV. -Positive opinion for an ... See all stories on this topic » | ||
| AstraZeneca Paying Big Over Seroquel Marketing WalletPop The New York AG's office said the drug company agreed to stop marketing Seroquel for unapproved uses. The settlement, filed in state court, also contains financial penalties and provisions against AstraZeneca intended to stop it from paying money to ... See all stories on this topic » | ||
| AstraZeneca To Pay $68.5 Million To States Over Seroquel Marketing Mediapost.com Thirty-seven US states and the District of Columbia will get $68.5 million from London-based AstraZeneca to settle out-of-court allegations that it deceptively marketed its anti-psychotic drug Seroquel. That settlement is separate from a $520 million ... See all stories on this topic » | ||
| Parnell says state should pick up tourism marketing cost Juneau Empire Parnell is criticizing legislators who refused to provide tourism marketing money he'd sought, and says their actions will threaten the state's tourism economy. "It's kind of an awful kick in the butt by them," Parnell told reporters Thursday. ... See all stories on this topic » |
Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment